X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with ALEMBIC PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs ALEMBIC PHARMA - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD ALEMBIC PHARMA STRIDES SHASUN LTD/
ALEMBIC PHARMA
 
P/E (TTM) x 15.3 28.5 53.5% View Chart
P/BV x 1.8 6.5 27.2% View Chart
Dividend Yield % 0.6 0.7 77.3%  

Financials

 STRIDES SHASUN LTD   ALEMBIC PHARMA
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
ALEMBIC PHARMA
Mar-16
STRIDES SHASUN LTD/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs1,275792 161.0%   
Low Rs918443 207.2%   
Sales per share (Unadj.) Rs389.6167.0 233.2%  
Earnings per share (Unadj.) Rs28.038.2 73.3%  
Cash flow per share (Unadj.) Rs48.942.0 116.4%  
Dividends per share (Unadj.) Rs4.504.00 112.5%  
Dividend yield (eoy) %0.40.6 63.3%  
Book value per share (Unadj.) Rs303.184.9 357.0%  
Shares outstanding (eoy) m89.42188.52 47.4%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.83.7 76.1%   
Avg P/E ratio x39.216.2 242.3%  
P/CF ratio (eoy) x22.414.7 152.5%  
Price / Book Value ratio x3.67.3 49.7%  
Dividend payout %16.110.5 153.5%   
Avg Mkt Cap Rs m98,036116,383 84.2%   
No. of employees `0005.8NA-   
Total wages/salary Rs m5,8814,214 139.6%   
Avg. sales/employee Rs Th6,005.9NM-  
Avg. wages/employee Rs Th1,014.0NM-  
Avg. net profit/employee Rs Th431.2NM-  
INCOME DATA
Net Sales Rs m34,83431,487 110.6%  
Other income Rs m1,68655 3,059.5%   
Total revenues Rs m36,52031,542 115.8%   
Gross profit Rs m6,42810,060 63.9%  
Depreciation Rs m1,872722 259.2%   
Interest Rs m2,26937 6,166.6%   
Profit before tax Rs m3,9739,356 42.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m4-2 -240.0%   
Extraordinary Inc (Exp) Rs m-1,0060-   
Tax Rs m4702,160 21.8%   
Profit after tax Rs m2,5017,194 34.8%  
Gross profit margin %18.531.9 57.8%  
Effective tax rate %11.823.1 51.2%   
Net profit margin %7.222.8 31.4%  
BALANCE SHEET DATA
Current assets Rs m38,16515,066 253.3%   
Current liabilities Rs m30,4027,674 396.2%   
Net working cap to sales %22.323.5 94.9%  
Current ratio x1.32.0 63.9%  
Inventory Days Days7767 115.5%  
Debtors Days Days10441 257.1%  
Net fixed assets Rs m37,6398,237 456.9%   
Share capital Rs m894377 237.2%   
"Free" reserves Rs m26,21015,416 170.0%   
Net worth Rs m27,10516,005 169.3%   
Long term debt Rs m16,3770-   
Total assets Rs m81,16824,594 330.0%  
Interest coverage x2.8255.2 1.1%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.41.3 33.5%   
Return on assets %5.929.4 20.0%  
Return on equity %9.244.9 20.5%  
Return on capital %12.158.7 20.5%  
Exports to sales %055.7 0.0%   
Imports to sales %010.4 0.0%   
Exports (fob) Rs mNA17,551 0.0%   
Imports (cif) Rs mNA3,283 0.0%   
Fx inflow Rs m13,46517,811 75.6%   
Fx outflow Rs m4,0765,318 76.6%   
Net fx Rs m9,38912,493 75.2%   
CASH FLOW
From Operations Rs m2,8819,304 31.0%  
From Investments Rs m-7,051-3,105 227.1%  
From Financial Activity Rs m3,382-1,959 -172.6%  
Net Cashflow Rs m-7884,240 -18.6%  

Share Holding

Indian Promoters % 27.7 74.1 37.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 37.8 2.9 1,303.4%  
FIIs % 8.6 9.1 94.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.9 13.9 186.3%  
Shareholders   56,241 49,328 114.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   NATCO PHARMA  PLETHICO PHARMA  FDC LTD.  ABBOTT INDIA  FRESENIUS KABI ONCO.  

Compare STRIDES SHASUN LTD With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Volatile Note; Airtel, Idea Down by 5%(01:30 pm)

After opening the day in green share markets in India witnessed choppy trading activity and are presently trading above the dotted line.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

'Smart Money' Enters Bitcoin. Will You?(Smart Contrarian)

Jan 17, 2018

As institutional money enters bitcoin, the gains over the last year could just be the tip of the iceberg.

Increasing Divergence Between Bond Yields and Earnings Yield(Chart Of The Day)

Jan 11, 2018

Over the past couple of months, bond yields have risen, but earning yields have fallen, increasing divergence.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Jan 24, 2018 01:49 PM

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD - FRESENIUS KABI ONCO. COMPARISON

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS